Since most HCC patients already suffer from chronic inflammatory conditions of the liver, the appearance of liver auto-antigens and activation of CD8+ T cells due to in situ vaccination may trigger hepatic irAEs. This evidence concerns the gene CD8A and hepatocellular carcinoma.